Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 9 - Medicinal preparations characterised by special physical form
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
05/2014
05/13/2014CA2748895C Pharmaceutical compositions with superior product performance and patient compliance
05/13/2014CA2692302C Method for utilizing neutral lipids to modify in vivo release from multivesicular liposomes
05/13/2014CA2677631C Olopatadine formulations for topical nasal administration
05/13/2014CA2665226C Novel formulations of proton pump inhibitors and methods of using these formulations
05/13/2014CA2659026C Pharmaceutical form with multilayer separating layer
05/13/2014CA2644694C Triggered self-assembly conjugates and nanosystems
05/13/2014CA2623031C Antifungal composition
05/13/2014CA2618966C Bitterness-reducing agent
05/13/2014CA2599018C Methods and systems for operating an aerosol generator
05/13/2014CA2595481C A tetracycline metal complex in a solid dosage form
05/13/2014CA2594981C Anthelmintic composition
05/13/2014CA2566310C Scored pharmaceutical tablets comprising a plurality of segments
05/13/2014CA2550704C Nicotine transdermal delivery system
05/13/2014CA2539872C Compositions for conjugated estrogens and associated methods
05/13/2014CA2518780C Drug composition having active ingredient adhered at high concentration to spherical core
05/13/2014CA2513759C Ceramic based nanoparticles for entrapping therapeutic agents for photodynamic therapy and method of using same
05/13/2014CA2506850C Compounds and methods for increasing neurogenesis
05/13/2014CA2386014C Influenza vaccine
05/13/2014CA2270345C Immunostimulatory nucleic acid molecules
05/09/2014CA2795324A1 Pharmaceutical compositions comprising hydromorphone and naloxone
05/08/2014WO2014071371A1 Cocrystals of (n,n-diethylcarbamoyl)methyl methyl (2e)but-2-ene-1,4-dioate
05/08/2014WO2014071212A2 Stable dual variable domain immunoglobulin protein formulations
05/08/2014WO2014071207A1 Particles for the treatment of inflammatory bowel disease
05/08/2014WO2014071190A1 Egcg stabilized gold nanoparticles and method for making same
05/08/2014WO2014071122A1 Pharmaceutical compositions for the treatment of cftr mediated diseases
05/08/2014WO2014071053A2 Improvements on tissue sealant for use in non-compressible hemorrhage
05/08/2014WO2014070723A1 Drug delivery particle formulations with targeting moieties
05/08/2014WO2014070622A1 Propynylaminoindan transdermal compositions
05/08/2014WO2014070589A1 Easy access bandages, packaging, and systems for application
05/08/2014WO2014070485A1 Dissolvable strip for treatment of oral thermal burns
05/08/2014WO2014070201A1 Cationic micelles with anionic polymeric counterions compositions, methods and systems thereof
05/08/2014WO2014070111A1 A novel reagent for gene-drug therapeutics
05/08/2014WO2014070038A1 Solid dosage form having neuroprotective, antiamnesic, antioxidant, antihypoxic and anti-ischemic activity (variants)
05/08/2014WO2014069792A1 Pack for supplying carbon dioxide to skin
05/08/2014WO2014069757A1 Stabilizer for hyaluronidase and liquid formulation comprising hyaluronidase
05/08/2014WO2014069655A1 Immune-tolerance inducer
05/08/2014WO2014069631A1 Vesicle composition, and external preparation for skin and cosmetic preparation each of which contains same
05/08/2014WO2014069615A1 Retinoic acid microneedle
05/08/2014WO2014069401A1 Pulmonary disease-specific therapeutic agent
05/08/2014WO2014068600A1 Stable transdermal pharmaceutical drug delivery system comprising diclofenac
05/08/2014WO2014068586A2 Solid oral compositions of tolvaptan
05/08/2014WO2014068585A1 Novel lyophilized compositions of cyclophosphamide
05/08/2014WO2014068507A1 Solid oral pharmaceutical compositions of telmisartan, essentially free of surfactants
05/08/2014WO2014068372A1 Pharmaceutical composition of tapentadol for parenteral administration
05/08/2014WO2014068085A1 Composition comprising cytokine macro-aggregates
05/08/2014WO2014068029A1 Lyophilized formulation comprising gm-csf neutralizing compound
05/08/2014WO2014068028A1 Topical parasiticidal formulation
05/08/2014WO2014067986A1 Galactoside inhibitor of galectin-3 and its use for treating pulmonary fibrosis
05/08/2014WO2014067933A1 Bioactive carrier preparation for enhanced safety in care products and food
05/08/2014WO2014067699A1 Administration of aerosolised iloprost
05/08/2014WO2014067637A1 Fat system for use in foods, cosmetics or pharmaceuticals
05/08/2014WO2014067501A1 Dispersible tablets containing deferasirox
05/08/2014WO2014043110A3 Crosslinked polymer nano-assemblies and uses thereof
05/08/2014WO2014041489A3 Rapidly dissolving pharmaceutical composition
05/08/2014WO2014018066A3 Mass production of suspension for treating thrombocytopenia
05/08/2014WO2013186390A9 Selective crystallization processes using reverse micelle and w/o microemulsion systems - multitask emulsion crystallization (mec)
05/08/2014WO2013092424A3 Active ingredient combinations comprising one or more polyols and one or more physiologically harmless hydroxamic acids, and cosmetic or dermatological preparations containing such active substance combinations
05/08/2014WO2013039621A3 Methods and systems for making microtablets for drug delivery
05/08/2014WO2013028897A3 The use of eating detection to control the release of biologically active agents
05/08/2014WO2013006729A3 Cannabinoid receptor binding agents, compositions and methods
05/08/2014WO2012178184A3 Removable protective shell for imaging agents and bioactive substances
05/08/2014WO2012149116A3 Liposomal vancomycin for the treatment of mrsa infections
05/08/2014WO2012147084A3 Oxymetazoline for the treatment of ano-rectal disorders
05/08/2014WO2012142372A3 Compositions and methods for the treatment of nasal conditions
05/08/2014WO2012138739A3 Compositions and methods for treating cancer
05/08/2014WO2006135362A9 Aqueous sustained-release drug delivery system for highly water-soluble electrolytic drugs
05/08/2014US20140128494 On-demand photoinitiated polymerization
05/08/2014US20140128477 Enhanced moisture barrier immediate release film coating systems and substrates coated therewith
05/08/2014US20140128443 Liquid Formulations Of Bendamustine
05/08/2014US20140128416 Medical devices incorporating collagen inhibitors
05/08/2014US20140128407 Fast dissolving azaperone granulate formulation
05/08/2014US20140128379 Nasal formulations of benzodiazepine
05/08/2014US20140128345 Vaginal matrices: nanofibers for contraception and prevention of hiv infection
05/08/2014US20140128343 Complex of amorphous tomoxiprole and cyclodextrin with fast dissolution rate and process for the preparation thereof
05/08/2014US20140127333 Preparation, process and a regenerative method and technique for prevention, treatment and glycemic control of diabetes mellitus
05/08/2014US20140127323 Dietetic multi-component system
05/08/2014US20140127320 Delivery of biologically-active agents using volatile, hydrophobic solvents
05/08/2014US20140127311 Bio-compatible nano-polymer particles comprising active ingredients for pulmonary application
05/08/2014US20140127310 Treatment of disease with poly-n-acetylglucosamine nanofibers
05/08/2014US20140127309 Encapsulated polar materials and methods of preparation
05/08/2014US20140127308 Encapsulated cells for hormone replacement therapy
05/08/2014US20140127307 Micropellet compositions comprising pancreatin containing digestive enzyme mixture
05/08/2014US20140127306 Modified Release Formulations Containing Drug-Ion Exchange Resin Complexes
05/08/2014US20140127305 Multifunctional nanoparticle designs and applications
05/08/2014US20140127304 Process for preparing solid amorphous particles comprising tiotropium bromide and a co-solid
05/08/2014US20140127303 Sustained-release composition containing peptides as active ingredient
05/08/2014US20140127301 Adjuvant Incorporation in Immunonanotherapeutics
05/08/2014US20140127299 GRAS Enteric Coating Formulations and Methods of Making and Using Same
05/08/2014US20140127298 Mucosomal allergen-specific immunotherapy with initial dosing after start of pollen season
05/08/2014US20140127296 Pharmaceutical preparation and method for treatment of diabetes
05/08/2014US20140127294 Oral solid formulation of compound anti-tubercular drug and preparation method thereof
05/08/2014US20140127293 Calcium Carbonate Granulation
05/08/2014US20140127292 Pharmaceutical compositions for the oral administration of heparin or derivatives thereof
05/08/2014US20140127291 Extended release acetaminophen liquid pharmaceutical compositions
05/08/2014US20140127287 Liposome-encapsulated hydrogels for use in a drug delivery system
05/08/2014US20140127282 Membrane
05/08/2014US20140127281 Propynylaminoindan transdermal compositions
05/08/2014US20140127280 Intrauterine delivery system for contraception
05/08/2014US20140127278 Method Of Treating Vascular Disease In Diabetic Patients
05/08/2014US20140127272 Nanometer-sized prodrugs of nsaids
1 ... 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 ... 2991